Burke Pharmaceuticals is committed to a multifaceted business approach in order to deliver sustainable growth and value to its investors. We are seeking potential partnering and collaboration opportunities, with pharmaceutical and medical device companies in the developed and developing markets, with the goal of creating a win-win partnership. Companies that have established themselves in the growing dermatology markets and have interest in adding innovative products to their portfolio may find Burke’s products complimentary to their strategic objectives.
Burke Pharmaceuticals is finalizing an agreement to develop a topical product with Hawthorne Pharmaceuticals. The product will be used in the treatment of Atopic Dermatitis for children and adults. Currently, a Pre-IND meeting is scheduled 1Q 2010. Under the proposed agreement, Burke Pharmaceuticals will contribute financing and intellectual property to the product..
Click to Download

Slideshow Version
